Cyclophosphamide in the treatment of pemphigus vulgaris and bullous pemphigoid.
D000328:Adult; D000368:Aged; D000505:Alopecia / Q000139:chemically induced; D002386:Cataract / Q000139:chemically induced; D002648:Child; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D003920:Diabetes Mellitus / Q000139:chemically induced; D005260:Female; D006801:Humans; D007970:Leukopenia / Q000139:chemically induced; D008297:Male; D008875:Middle Aged; D010024:Osteoporosis / Q000139:chemically induced; D010392:Pemphigus / Q000188:drug therapy*; D011241:Prednisone / Q000008:administration & dosage / Q000009:adverse effects; D011605:Psychoses, Substance-Induced; D012871:Skin Diseases / Q000188:drug therapy*
D003520:Cyclophosphamide; D011241:Prednisone